Your browser doesn't support javascript.
loading
Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study.
Reich, K; Pinter, A; Lacour, J P; Ferrandiz, C; Micali, G; French, L E; Lomaga, M; Dutronc, Y; Henneges, C; Wilhelm, S; Hartz, S; Paul, C.
Afiliação
  • Reich K; Dermatologikum Hamburg, Stephansplatz 5, 20354, Hamburg, Germany.
  • Pinter A; Georg-August-University, Göttingen, Germany.
  • Lacour JP; Department of Dermatology, Venereology, and Allergology, University Clinic Frankfurt, Frankfurt am Main, Germany.
  • Ferrandiz C; Department of Dermatology, University Hospital of Nice, Nice, France.
  • Micali G; Servicio de Dermatología, Hospital Universitario Germans Trias i Pujol, Universitat Autónoma de Barcelona, Badalona, Barcelona, Spain.
  • French LE; Dermatology Clinic, University of Catania, University Hospital Policlinico-Vittorio Emanuele, Catania, Sicily, Italy.
  • Lomaga M; Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland.
  • Dutronc Y; DermEdge Research, Mississauga, ON, Canada.
  • Henneges C; Eli Lilly and Company, Indianapolis, IN, U.S.A.
  • Wilhelm S; Eli Lilly and Company, Indianapolis, IN, U.S.A.
  • Hartz S; Eli Lilly and Company, Indianapolis, IN, U.S.A.
  • Paul C; Eli Lilly and Company, Indianapolis, IN, U.S.A.
Br J Dermatol ; 177(4): 1014-1023, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28542874

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados / Ustekinumab Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados / Ustekinumab Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article